Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulating IL-11-dependent matrix stiffness to delay ovarian aging.

Nature aging·2026
Same author

CAV1-dependent mitochondrial transfer from hucMSCs reprograms epithelial lipid metabolism to relieve pulmonary fibrosis.

Stem cell research & therapy·2026
Same author

Baozhu Granule as a Novel Treatment Strategy for Diminished Ovarian Reserve: A Prospective Clinical Trial.

Rejuvenation research·2026
Same author

Prokaryotically expressed IBDV VP2 virus-like particles: Stability and protective efficacy.

Microbial pathogenesis·2026
Same author

Poly(Lactic Acid) Nanofiber Membrane Loaded with Tannins from Charred Sanguisorbae Radix with Antioxidant and Antibacterial Activities for Potential Wound Healing Applications.

Applied biochemistry and biotechnology·2026
Same author

A ferritin-based mosaic-like nanovaccine elicits effective cross-protection against H1N1 and H3N2 swine influenza viruses.

Journal of nanobiotechnology·2026

Related Experiment Video

Updated: Jun 12, 2025

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids
08:22

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids

Published on: August 11, 2017

15.7K

[3D bioprinting: classification, evaluation, and application in vascular tissue engineering].

Xiafei Li1, Huanhuan Yan2, Tuo Yang2

  • 1School of Medical Engineering, Xinxiang Medical University, Xinxiang 453003, Henan, China.

Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|September 25, 2024
PubMed
Summary
This summary is machine-generated.

3D bioprinting offers a promising solution for creating artificial blood vessels, overcoming limitations in traditional tissue engineering methods for cardiovascular disease treatments.

Keywords:
3D bioprintingbio-inkclassification and evaluationcomposite materialtissue-engineered blood vessel

More Related Videos

Fabrication of Engineered Vascular Flaps Using 3D Printing Technologies
08:31

Fabrication of Engineered Vascular Flaps Using 3D Printing Technologies

Published on: May 19, 2022

3.8K
Author Spotlight: Automated Bioprinting for High-Throughput Vascular Model Fabrication
07:41

Author Spotlight: Automated Bioprinting for High-Throughput Vascular Model Fabrication

Published on: August 16, 2024

928

Related Experiment Videos

Last Updated: Jun 12, 2025

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids
08:22

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids

Published on: August 11, 2017

15.7K
Fabrication of Engineered Vascular Flaps Using 3D Printing Technologies
08:31

Fabrication of Engineered Vascular Flaps Using 3D Printing Technologies

Published on: May 19, 2022

3.8K
Author Spotlight: Automated Bioprinting for High-Throughput Vascular Model Fabrication
07:41

Author Spotlight: Automated Bioprinting for High-Throughput Vascular Model Fabrication

Published on: August 16, 2024

928

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Cardiovascular Engineering

Background:

  • Cardiovascular diseases necessitate effective treatments, yet small-diameter artificial blood vessels for coronary artery bypass surgery remain scarce.
  • Conventional vascular scaffold fabrication methods struggle with precise control over diameter, shape, and pore interconnectivity.
  • Existing tissue engineering approaches for vascular grafts face significant limitations.

Purpose of the Study:

  • To systematically review and evaluate 3D bioprinting technologies for vascular tissue engineering.
  • To highlight the advancements and potential of 3D bioprinting in creating vascular scaffolds.
  • To identify challenges and future research directions in this field.

Main Methods:

  • Review of current 3D bioprinting techniques applicable to vascular tissue engineering.
  • Analysis of research progress in utilizing 3D bioprinting for vascular scaffold fabrication.
  • Evaluation of the advantages and limitations of 3D bioprinting in this context.

Main Results:

  • 3D bioprinting allows for precise control over scaffold architecture, including nanoscale microstructure and porosity.
  • It enables the accurate deposition of cells and biomaterials, mimicking natural vascular tissue structure.
  • This technology offers enhanced capabilities for creating patient-specific vascular grafts.

Conclusions:

  • 3D bioprinting presents a significant advancement over traditional methods for vascular tissue engineering.
  • Addressing challenges like immune rejection of biomaterials is crucial for clinical translation.
  • Further research is needed to optimize 3D bioprinting strategies for small-diameter vascular applications.